METabolic EXplorer: Update on the L-Methionine program

METabolic EXplorer: Financial results, fourth quarter 2015
19 February 2016
Show all

METabolic EXplorer: Update on the L-Methionine program

Download the press release

Clermont-Ferrand, 4 January 2016 – METabolic EXplorer, a biological chemistry company that specialises in developing manufacturing bioprocesses for bio-based compounds used in a wide range of everyday products, including textile fibres, animal feed supplements and resins, makes an update about the L-Methionine program progress.

METabolic EXplorer confirms that good progress is being made in talks with several manufacturers to conclude non-exclusive agreements for the production of 100% bio-based L-Methionine. Letters of intent have already been signed with several parties, and nothing at this stage weakens its confidence in the successful commercialization of this technology. However, the negotiations involved in addressing the manufacturing issues at this level in order to transform these letters of intent into binding agreements with international groups are understandably long. METabolic EXplorer remains confident of a positive outcome in at least one of these negotiations.



About METabolic EXplorer-

METabolic EXplorer is a biological chemistry company which was incorporated in 1999. Its goal is to help industrial businesses deal with the rise in oil prices, so that they can continue their production, in a different, sustainable way.

Based on the tried and tested principle of industrial fermentation, METabolic EXplorer’s solutions replace today’s petrochemical processes with the use of a wide range of plant-based raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, plastics, resins, solvents or animal feed supplements).

METabolic EXplorer is currently focusing its alternative processes on the production of three compounds that together have an estimated, annual, end-market value of €7 billion. The company’s strategy will be implemented through industrial partnerships in the shape of licenses and joint ventures, as well as own-account production units.

METabolic EXplorer, based in Clermont-Ferrand, France, is listed on Euronext in Paris (Compartment C, METEX) and is part of the CAC Small index and EnterNext Tech40 label.


Get free financial information on METabolic EXplorer by registering with: or

 Media and individual shareholder relations
ATTITUDE Corporate
Eric de Lambert
Tél.: +33 (0)6 2529 0658

Investor and analyst relations
ACTUS finance & communication
Jérôme Fabreguettes-Leib
Tél. : +33 (0)1 5367 3678

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.